CMP-001Published on: 18 Apr 2018
Mohammed Milhem on the combination of CMP-001 + Pembro
Mohammed Milhem presents preliminary data on the combination of the TLR9 agonist CMP-001 and pembrolizumab in patients with metastatic melanoma resistant to anti-PD-1.